How Navana Pharma made profit even in crisis
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Tuesday
January 31, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
TUESDAY, JANUARY 31, 2023
How Navana Pharma made profit even in crisis

Economy

TBS Report
18 October, 2022, 10:50 pm
Last modified: 18 October, 2022, 10:56 pm

Related News

  • Navana Pharma’s profit grows 16% in Jul-Dec
  • Navana Pharma IPO subscription opens on 13 September
  • Navana Pharma share cut-off price set at Tk34
  • Bidding for determining Navana Pharma’s share price ends Thursday
  • Navana Pharma’s bidding starts on 4 July to set a cut-off price

How Navana Pharma made profit even in crisis

TBS Report
18 October, 2022, 10:50 pm
Last modified: 18 October, 2022, 10:56 pm
Infographic: TBS
Infographic: TBS

Navana Pharmaceuticals Limited – which made its stock market debut yesterday under the 'N' category – has registered a handsome year-on-year growth in its business for the first nine months of fiscal 2021-22, thanks to massive sales in both local and foreign markets. 

The drug maker's profit increased by 45% to Tk19.18 crore, compared to the same period of FY21.

In the July to March period of FY22, its revenue stood at Tk366.22 crore, which was not only greater than that in the same nine months of the previous year but also higher than the annual revenue of FY21. The revenue in FY21 was Tk360.65 crore.

However, EBL Securities pointed out in its initial public offering (IPO) note about Navana Pharma that the company's profit margin for the nine-month period is lower than the industry average.

The note also reads that Navana Pharma's short-term loans increased by around 144%, pushing its financial expenses up by 158%.

EBL Securities further said that the drug maker's board of directors lacks diversity as it comprises mostly members from one family. Hence, any family dispute or conflict of interest can directly induce adversities in the company's future.

Earlier, the Bangladesh Securities and Exchange Commission (BSEC) allowed Navana Pharma to raise Tk75 crore through an IPO.

Its cut-off price was fixed at Tk34 per share through the electronic subscription system.

Qualified and institutional investors including mutual funds got 25% of shares at the cut-off price, whereas individual investors got the remaining shares at Tk23.8 each – a 30% discount on the cut-off price.

Incorporated in 1986, Navana Pharma operates in two categories of pharmaceuticals: veterinary and human health.

The veterinary division manufactures and markets more than 123 high-quality medicines and feed supplements that include poultry, dairy, and aqua products.

While the human health division produces more than 277 drugs as tablets, capsules, oral liquids, ampoules, dry powder vials, powders for suspension, eye drops, creams and ointments, and more.

Top News

Navana Pharma

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
    IMF approves Bangladesh's $4.5 billion loan proposal
  • Despite downturn 3 dozen listed firms plan Tk7,500cr investment
    Despite downturn 3 dozen listed firms plan Tk7,500cr investment
  • Mysterious resignation of SIBL chairman, addl MD
    Mysterious resignation of SIBL chairman, addl MD

MOST VIEWED

  • Top 20 defaulters owe Tk16,588 crore to lenders: Finance minister
    Top 20 defaulters owe Tk16,588 crore to lenders: Finance minister
  • TBS file photo
    Z&Z Fabrics introduces Sorona fabric line
  • Cry for dollar for Ramadan imports
    Cry for dollar for Ramadan imports
  • Manufacturers feel the pinch as consumers tighten belt
    Manufacturers feel the pinch as consumers tighten belt
  • Illustration: TBS
    Biz leaders want crisis management, energy security for survival
  • Infograph: TBS
    State banks spend 80% of their forex for govt imports in H1

Related News

  • Navana Pharma’s profit grows 16% in Jul-Dec
  • Navana Pharma IPO subscription opens on 13 September
  • Navana Pharma share cut-off price set at Tk34
  • Bidding for determining Navana Pharma’s share price ends Thursday
  • Navana Pharma’s bidding starts on 4 July to set a cut-off price

Features

Photo: Courtesy

The Hawkers: Where minimalism meets motifs

17h | Brands
TBS illustration

Where do Shariah-compliant mutual funds stand in Bangladesh

16h | Panorama
Sketch: TBS

A subsidy war without winners

16h | Panorama
Photo: Collected

Oppo Reno 8T first look revealed!

17h | Brands

More Videos from TBS

two more factories of the country got platinum certificate.

two more factories of the country got platinum certificate.

8h | TBS Today
Iconic villains of Bollywood

Iconic villains of Bollywood

9h | TBS Entertainment
General knowledge "Gravity"

General knowledge "Gravity"

7h | Videos
Will tanks turn the tide for Ukraine?

Will tanks turn the tide for Ukraine?

8h | TBS World

Most Read

1
Picture: Collected
Bangladesh

US Embassy condemns recent incidents of visa fraud

2
Illustration: TBS
Banking

16 banks at risk of capital shortfall if top 3 borrowers default

3
Bapex calls candidates for job test 9 years after advert!
Bangladesh

Bapex calls candidates for job test 9 years after advert!

4
Photo: Collected
Splash

Hansal Mehta responds as Twitter user calls him 'shameless' for making Faraaz

5
A frozen Beyond Burger plant-based patty. Photographer: AKIRA for Bloomberg Businessweek
Bloomberg Special

Fake meat was supposed to save the world. It became just another fad

6
Representational Image
Banking

Cash-strapped Islami, Al-Arafah and National turn to Sonali Bank for costly fund

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net